MA Fletcher

Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study Group

MA Fletcher, J. W. Mosley, Joseph M. Hassett et al. · Blood · 1992 · 28 citations · Full text

Medicine, Hematology, Immunology +13

Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study Group

Joseph M. Hassett, GF Gjerset, J. W. Mosley et al. · Blood · 1993 · 23 citations · Full text

Medicine, Hematology, Immunology +16

Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group

GF Gjerset, MC Pike, J. W. Mosley et al. · Blood · 1994 · 12 citations · Full text

Medicine, Hematology, Infectious Diseases +14

Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group

GF Gjerset, MC Pike, J. W. Mosley et al. · Blood · 1994 · 12 citations · Full text

Medicine, Hematology, Infectious Diseases +14